Sangui Biotech International (Sangui Biotech International) Operating Cash Flow per Share

: $0.00 (TTM As of Mar. 2023)

View and export this data going back to . Start your Free Trial

Sangui Biotech International's operating cash flow per share for the three months ended in Mar. 2023 was $0.00. Sangui Biotech International's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Sangui Biotech International's Operating Cash Flow per Share or its related term are showing as below:

SGBI's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.75
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Sangui Biotech International Operating Cash Flow per Share Historical Data

The historical data trend for Sangui Biotech International's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangui Biotech International Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Operating Cash Flow per Share

Get a 7-Day Free Trial

Sangui Biotech International Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sangui Biotech International's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sangui Biotech International Price-to-Operating-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Sangui Biotech International's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sangui Biotech International's Price-to-Operating-Cash-Flow falls into.

Sangui Biotech International Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Sangui Biotech International's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2022 is calculated as

Operating Cash Flow per Share (A: Jun. 2022 )	=	Cash Flow from Operations (A: Jun. 2022 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2022 )
	=	-0.14	/	208.605
	=	-0.00

Sangui Biotech International's Operating Cash Flow per Share for the quarter that ended in Jun. 2022 is calculated as

Operating Cash Flow per Share (Q: Mar. 2023 )	=	Cash Flow from Operations (Q: Mar. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2023 )
	=	0	/	209.956
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

Sangui Biotech International Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Sangui Biotech International's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Sangui Biotech International (Sangui Biotech International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sangui Biotech International Inc (OTCPK:SGBI) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

SBH:Germany

Address

Bleichenbrucke 9, Hamburg, DEU, 20354

Website

http://www.sanguibiotech.com

Sangui Biotech International Inc develops pharmaceutical, medical and cosmetic products, through its subsidiary. The company develops oxygen carriers for providing oxygen transport in humans due to acute or chronic lack of oxygen and in the case of chronic wounds. It has also developed external applications of oxygen transporters in the form of sprays for healing chronic wounds and gels and emulsions for the regeneration of the skin. The products offered are artificial oxygen carriers; Chitoskin wound pads; and haemoglobin-based wound spray technology sold under the brand name Granulox. It derives revenue from licensing fees on sales of its wound spray product.

Executives

Hubertus Schmelz	director	NEUER WALL 54, HAMBURG 2M D-20354
Joachim Fleing	director	ALFRED HERRHAUSENSTR 44, WITTEN 2M 58455
Thomas Striepe	director	NEUER WALL 54, HAMBURG 2M D-20354
Wolfgang Barnikol	director	ALFRED HERRHAUSEN STR 44, WITTEN 2M 58455
Lutz Joachim	director	ALFRED-HERRHAUSEN-ST. 44, WITTEN 2M 58455
Christoph Ludz	director	SANDERSKOPPEL 17, HAMBURG 2M 22391

Sangui Biotech International (Sangui Biotech International) Headlines

No Headlines